Soliton Selects RESONIC as Brand Name for FDA-Cleared Rapid Acoustic Pulse Device
The initial launch of the RESONIC brand for tattoo and cellulite indications is expected in Q2 of 2021.
The initial launch of the RESONIC brand for tattoo and cellulite indications is expected in Q2 of 2021.
New proposals would limit high-risk aesthetic procedures to qualified healthcare professionals, restrict treatments for minors, and introduce penalties for unqualified providers.